Abstract
The term pseudoporphyria describes a cutaneous condition that mimics porphyria cutanea tarda (PCT) in adults and erythropoietic protoporphyria in children. Pseudoporphyria is frequently linked to the ingestion of drugs, primarily nonsteroidal anti-inflammatory drugs (NSAIDs). The course is prolonged in some patients, but most reports describe symptoms that disappear several weeks to several months after the offending agent is withdrawn. These authors retrospectively studied patients with pseudoporphyria who were treated at the Mayo Clinic between 1992 and 1996. Normal porphyrin levels were required for a …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
